Balance Sheet for Corbus Pharmaceuticals Holdings Inc. (CRBP)

$ 1.22   0.01 (+0.83%) Volume: 3.36m 4:00 PM EST Nov 23, 2020
After Hours:  $ 1.25   0.03 (+2.46%) Volume: 76.88k 7:28 PM EST Nov 23, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 31,749 41,748 62,537 14,992 12,338
Restrictable Cash - - 159 150 -
Marketable Securities - - - - -
Accounts Receivable 2,681 - 500 1,000 -
Loans Receivable - - - - -
Other Receivables 2,681 - - 330 -
Receivables 2,681 - 500 1,330 -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 3,725 2,492 2,808 930 377
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 38,155 44,240 65,505 17,403 12,715
Land and Improvements - - - - -
Buildings and Improvement 4,150 2,025 191 188 19
Machinery, Furniture and Equipment 2,339 1,346 424 355 75
Construction in Progress 1,436 - 1,182 - 84
Fixed Assets, Other 4,383 - - - -
Fixed Assets, Total 12,309 3,372 1,797 543 178
Gross Fixed Assets 12,309 3,372 1,797 543 178
Accumulated Depreciation (1,406) (667) (364) (108) (54)
Net Fixed Assets 10,903 2,705 1,433 435 124
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 85 44 41 50 36
Total Non-Current Assets 10,988 2,749 1,473 485 161
Total Assets 49,142 46,989 66,978 17,888 12,875
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 11,091 6,345 3,130 3,420 1,314
Short Term Debt 596 - - - -
Notes Payable 753 394 333 272 162
Accrued Expenses 18,775 7,598 3,406 2,478 562
Accrued Liabilities 18,775 7,598 3,406 2,478 562
Deferred Revenues - 1,463 - 1,940 1,591
Current Deferred Income Taxes - - - - -
Other Current Liabilities 3,673 2,290 1,336 789 -
Total Current Liabilities 34,888 18,089 8,205 8,899 3,630
Long Term Debt N/A N/A N/A 5 -
Deferred Income Tax - 1,376 990 66 260
Other Non-Current Liabilities - 1,376 990 66 260
Minority Interest - - - - -
Capital Lease Obligations 8,097 - 0 5 -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 8,097 1,376 990 70 260
Total Liabilities 42,985 19,465 9,195 8,969 3,890
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 6,158 27,524 57,784 8,919 8,985
Common Par 6 6 6 4 4
Additional Paid in Capital 198,975 148,889 123,476 42,191 22,259
Cumulative Translation Adjustments - - - - -
Retained Earnings (192,824) (121,370) (65,698) (33,276) (13,278)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 6,158 27,524 57,784 8,919 8,985
Total Equity 6,158 27,524 57,784 8,919 8,985
Total Liabilities & Shareholder's Equity 49,142 46,989 66,978 17,888 12,875
Cash Flow (71,454) (55,672) (32,422) (19,999) (8,851)
Working Capital 3,267 26,151 57,300 8,504 9,085
Free Cash Flow (48,463) (32,368) (28,504) (13,924) (4,762)
Invested Capital 6,158 27,524 57,784 8,919 8,985
Shares Outstanding - Common Class Only 64,673 57,247 55,603 44,682 37,605
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 64,673 57,247 55,603 44,682 37,605
Total Common Shares Outstanding 64,673 57,247 55,603 44,682 37,605
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 63,899 57,000 50,177 41,138 31,350
Diluted Weighted Shares Outstanding 63,899 57,000 50,177 41,138 31,350